# A Pilot Trial of Rituxan in Refractory Myasthenia Gravis

> **NCT00619671** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Vermont** · enrollment: 10 (estimated)

## Conditions studied

- Refractory Myasthenia Gravis

## Interventions

- **DRUG:** Rituximab (Rituxan)

## Key facts

- **NCT ID:** NCT00619671
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2013-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619671, "A Pilot Trial of Rituxan in Refractory Myasthenia Gravis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00619671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*